Patent · US Active

IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof

US12043669B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Leo Pharma A/S · DK

Inventors

Birgitte Ursø · Copenhagen, DK
Waseem Sajid · Taastrup, DK
Paola Lovato · Copenhagen, DK
Heidi Westh Bagger · Copenhagen, DK
Christoph Erkel · Planegg, DE
Petra Nussbaumer · Planegg, DE
Simon Schuster · Neuenburg am Rhein, DE

Key dates

Filing date	Nov 13, 2023
Grant date	Jul 23, 2024
Priority date	—
Expiry date	Nov 13, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides novel antibodies and fragments thereof targeting IL-1RAcP (Interleukin-1 receptor accessory protein). Use of IL-1RAcP inhibitors are also provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.